SDG Metadata/3-5-1 — English @ Hosted Weblate

23	Strings		100%	Browse Translate
3,315	Words		100%

23	All strings — 3,315 words	Browse Translate Zen
23	Read-only strings — 3,315 words	Browse Translate Zen
3	Strings with any failing checks — 857 words	Browse Translate Zen
3	Failing check: Multiple failing checks — 857 words	Browse Translate Zen

Component	Unfinished	Unfinished words	Unfinished characters	Untranslated	Checks	Suggestions	Comments
1-1-1a MIT	0	0	0	0	17	0	0

14-2-1 MIT	0	0	0	0	0	0	0

6-3-2 MIT	0	0	0	0	1	0	0

10-5-1 MIT	0	0	0	0	25	0	0

6-6-1a MIT	0	0	0	0	23	0	0

15-b-1 MIT	0	0	0	0	21	0	0

16-2-3 MIT	0	0	0	0	0	0	0

14-5-1 MIT	0	0	0	0	26	0	0

3-c-1 MIT	0	0	0	0	21	0	0

4-1-2 MIT	0	0	0	0	25	0	0

Project website	github.com/worldbank/sdg-metadata
Instructions for translators	This project is limited to Russian translation only, for now. More detailed instructions to come.
Project maintainers	brockfanning
Translation license	MIT License
Translation process	Translations can be made directly. Translation suggestions are turned off. Any authenticated user can contribute. The translation uses monolingual files. The translation base language can not be edited.
Source code repository	`https://github.com/worldbank/sdg-metadata`
Repository branch	master
Last remote commit	Merge pull request #541 from weblate/weblate-sdg-metadata-1-1-1a `2bbcb9a225a` brockfanning authored 3 months ago
Last commit in Weblate	Translated using Weblate (French) `7d40910a051` deblsyl authored a year ago
Weblate repository	`https://hosted.weblate.org/git/sdg-metadata/1-1-1a/`
File mask	`translations-metadata/*/3-5-1.yml`
Monolingual base language file	`translations-metadata/en/3-5-1.yml`
Translation file	Download `translations-metadata/en/3-5-1.yml`
Last change	None
Last author	None

	Strings percent	Hosted strings	Words percent	Hosted words	Characters percent	Hosted characters
Total		23		3,315		27,373
Translated	100%	23	100%	3,315	100%	27,373
Needs editing	0%	0	0%	0	0%	0
Read-only	100%	23	100%	3,315	100%	27,373
Failing checks	13%	3	25%	857	36%	10,058
Strings with suggestions	0%	0	0%	0	0%	0
Untranslated strings	0%	0	0%	0	0%	0

None Resource update SDG Metadata / 3-5-1 — English	File `translations-metadata/en/3-5-1.yml` was added. a year ago
None String updated in the repository SDG Metadata / 3-5-1 — English	English <p><strong>URLs:</strong> </p> <p><a href="https://www.who.int/gho/substance_abuse/en/" target="_blank"><u>https://www.who.int/gho/substance_abuse/en/</u></a> </p> <p><a href="https://wdr.unodc.org/wdr2019/" target="_blank"><u>https://wdr.unodc.org/wdr2019/</u></a> </p> <p><a href="https://www.who.int/healthinfo/global_burden_disease/about/en/" target="_blank"><u>https://www.who.int/healthinfo/global_burden_disease/about/en/</u></a> </p> <p><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5608813/" target="_blank"><u>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5608813/</u></a> </p> <p><a href="https://icd.who.int/browse10/2016/en" target="_blank"><u>https://icd.who.int/browse10/2016/en</u></a> </p> <p><u>https://www.unodc.org/unodc/en/commissions/CND/conventions.html</u> </p> <p><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2395571/" target="_blank"><u>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2395571/</u></a> </p> <p><a href="https://www.who.int/healthinfo/systems/monitoring/en/" target="_blank"><u>https://www.who.int/healthinfo/systems/monitoring/en/</u></a> </p> <p><u>https://www.unodc.org/unodc/en/GAP/</u> </p> <p><a href="https://www.unodc.org/documents/pakistan/Survey_Report_Final_2013.pdf" target="_blank"><u>https://www.unodc.org/documents/pakistan/Survey_Report_Final_2013.pdf</u></a> </p> <p><a href="https://www.unodc.org/documents/data-and-analysis/statistics/Drugs/Drug_Use_Survey_Nigeria_2019_BOOK.pdf" target="_blank"><u>https://www.unodc.org/documents/data-and-analysis/statistics/Drugs/Drug_Use_Survey_Nigeria_2019_BOOK.pdf</u></a> </p> <p><a href="https://www.who.int/substance_abuse/activities/gisah/en/" target="_blank"><u>https://www.who.int/substance_abuse/activities/gisah/en/</u></a> </p> <p><a href="https://www.who.int/substance_abuse/activities/gisah_indicatorbook.pdf?ua=1" target="_blank"><u>https://www.who.int/substance_abuse/activities/gisah_indicatorbook.pdf?ua=1</u></a> </p> English 1945 characters edited Current translation Read only <p><strong>URLs:</strong> </p> <p><a href="https://www.who.int/gho/substance_abuse/en/" target="_blank"><u>https://www.who.int/gho/substance_abuse/en/</u></a> </p> <p><a href="https://wdr.unodc.org/wdr2019/" target="_blank"><u>https://wdr.unodc.org/wdr2019/</u></a> </p> <p><a href="https://www.who.int/healthinfo/global_burden_disease/about/en/" target="_blank"><u>https://www.who.int/healthinfo/global_burden_disease/about/en/</u></a> </p> <p><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5608813/" target="_blank"><u>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5608813/</u></a> </p> <p><a href="https://icd.who.int/browse10/2016/en" target="_blank"><u>https://icd.who.int/browse10/2016/en</u></a> </p> <p><u>https://www.unodc.org/unodc/en/commissions/CND/conventions.html</u> </p> <p><a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2395571/" target="_blank"><u>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2395571/</u></a> </p> <p><a href="https://www.who.int/healthinfo/systems/monitoring/en/" target="_blank"><u>https://www.who.int/healthinfo/systems/monitoring/en/</u></a> </p> <p><u>https://www.unodc.org/unodc/en/GAP/</u> </p> <p><a href="https://www.unodc.org/documents/pakistan/Survey_Report_Final_2013.pdf" target="_blank"><u>https://www.unodc.org/documents/pakistan/Survey_Report_Final_2013.pdf</u></a> </p> <p><a href="https://www.unodc.org/documents/data-and-analysis/statistics/Drugs/Drug_Use_Survey_Nigeria_2019_BOOK.pdf" target="_blank"><u>https://www.unodc.org/documents/data-and-analysis/statistics/Drugs/Drug_Use_Survey_Nigeria_2019_BOOK.pdf</u></a> </p> <p><a href="https://www.who.int/substance_abuse/activities/gisah/en/" target="_blank"><u>https://www.who.int/substance_abuse/activities/gisah/en/</u></a> </p> <p><a href="https://www.who.int/substance_abuse/activities/gisah_indicatorbook.pdf?ua=1" target="_blank"><u>https://www.who.int/substance_abuse/activities/gisah_indicatorbook.pdf?ua=1</u></a> </p> a year ago
None String updated in the repository SDG Metadata / 3-5-1 — English	English <p><strong>Sources of discrepancies:</strong></p> <p>Given the heterogeneity of national data collection systems, there is potential for discrepancies related either to the differences in recording the number of people in treatment and for people with substance use disorders. For this purpose, the ARQ has recently been improved to allow for countries to specify the nature of the data reported and to enable UNODC to assess the accuracy and comparability of data. </p> <p> </p> <p>Apart from evaluating the consistency of data and addressing data discrepancies by using additional sources, UNODC is in continuous communication and discusses technical issues with reporting countries in order to minimize discrepancies and inconsistency of data. </p> English 751 characters edited Current translation Read only <p><strong>Sources of discrepancies:</strong></p> <p>Given the heterogeneity of national data collection systems, there is potential for discrepancies related either to the differences in recording the number of people in treatment and for people with substance use disorders. For this purpose, the ARQ has recently been improved to allow for countries to specify the nature of the data reported and to enable UNODC to assess the accuracy and comparability of data. </p> <p> </p> <p>Apart from evaluating the consistency of data and addressing data discrepancies by using additional sources, UNODC is in continuous communication and discusses technical issues with reporting countries in order to minimize discrepancies and inconsistency of data. </p> a year ago
None String updated in the repository SDG Metadata / 3-5-1 — English	English <p><strong>Data availability:</strong></p> <p>During the reporting period 2013-2017, 62 countries have provided data on drug use disorders and 98 countries provided data on drug treatment. The availability and accuracy of data on the number of people with drug use disorders and people in treatment for the use of drugs is gradually increasing. </p> <p>For the number of alcohol use disorders data are currently available for 188 Member States (for 2016) and validated through the process of country consultation. Data are regularly updated and presented through WHO Global Health Observatory. For utilization of treatment by people with alcohol use disorders, data are currently available for at least 30 countries and further data collection is ongoing </p> <p>For contextual information on treatment services, WHO has collected data from more than 85 countries; data collection for other is ongoing and to be accomplished till the end of 2019. </p> <p><strong>Time series: </strong></p> <p>During 2013-2017, 34 countries have provided at least two datapoints for both numerator and denominator necessary for the calculation of the SDG indicator on drug use disorders. With the improved ARQ, it is expected that the number of responses and quality of data reported will increase after 2021. For the alcohol, data on denominator are available for a long period since establishment of GISAH in 1997 and the indicator has been tentatively calculated for at least 30 countries in 2019, with contextual information available for 85. </p> <p><strong>Disaggregation:</strong></p> <p>Given the policy importance, the indicator will be disaggregated to provide data for drugs and alcohol. Depending on data availability, it will be additionally disaggregated by following: </p> <ul> <li>by treatment interventions (pharmacological, psychosocial, rehabilitation and aftercare) </li> <li>by sex </li> <li>by age groups </li> </ul> <p>In relation to drug use disorders, the following types of drugs should be considered: </p> <ul> <li>cannabis (including herb and resin) </li> <li>opioids (opium, heroin, medicinal products containing opioids and other opioids)), </li> <li>cocaine type, </li> <li>amphetamines (amphetamine, methamphetamine, medicinal products containing ATS), </li> <li>ecstasy-type substances, </li> <li>sedatives and tranquilizers, </li> <li>hallucinogens </li> <li>solvents and inhalants </li> <li>NPS </li> </ul> English 2448 characters edited Current translation Read only <p><strong>Data availability:</strong></p> <p>During the reporting period 2013-2017, 62 countries have provided data on drug use disorders and 98 countries provided data on drug treatment. The availability and accuracy of data on the number of people with drug use disorders and people in treatment for the use of drugs is gradually increasing. </p> <p>For the number of alcohol use disorders data are currently available for 188 Member States (for 2016) and validated through the process of country consultation. Data are regularly updated and presented through WHO Global Health Observatory. For utilization of treatment by people with alcohol use disorders, data are currently available for at least 30 countries and further data collection is ongoing </p> <p>For contextual information on treatment services, WHO has collected data from more than 85 countries; data collection for other is ongoing and to be accomplished till the end of 2019. </p> <p><strong>Time series: </strong></p> <p>During 2013-2017, 34 countries have provided at least two datapoints for both numerator and denominator necessary for the calculation of the SDG indicator on drug use disorders. With the improved ARQ, it is expected that the number of responses and quality of data reported will increase after 2021. For the alcohol, data on denominator are available for a long period since establishment of GISAH in 1997 and the indicator has been tentatively calculated for at least 30 countries in 2019, with contextual information available for 85. </p> <p><strong>Disaggregation:</strong></p> <p>Given the policy importance, the indicator will be disaggregated to provide data for drugs and alcohol. Depending on data availability, it will be additionally disaggregated by following: </p> <ul> <li>by treatment interventions (pharmacological, psychosocial, rehabilitation and aftercare) </li> <li>by sex </li> <li>by age groups </li> </ul> <p>In relation to drug use disorders, the following types of drugs should be considered: </p> <ul> <li>cannabis (including herb and resin) </li> <li>opioids (opium, heroin, medicinal products containing opioids and other opioids)), </li> <li>cocaine type, </li> <li>amphetamines (amphetamine, methamphetamine, medicinal products containing ATS), </li> <li>ecstasy-type substances, </li> <li>sedatives and tranquilizers, </li> <li>hallucinogens </li> <li>solvents and inhalants </li> <li>NPS </li> </ul> a year ago
None String updated in the repository SDG Metadata / 3-5-1 — English	English <p>At UNODC, quality assurance measures are in place to collect, process and disseminate statistical data. They build on the ‘Principles governing international statistical activities’ and regulate the collection, processing, publication and dissemination of data. </p> <p> </p> <p>All data for SDG indicators as compiled by the Office are sent to countries (through the relevant national focal points) for their review before statistical data are officially released by UNODC. When countries provide feedback/comments on the data, a technical discussion is conducted to identify a common position. </p> <p> </p> <p>At WHO quality assurance measures are in place for producing the health statistics that include the main indicators on alcohol consumption and its health consequences. WHO Technical Advisory Group on Alcohol and Drug Epidemiology provides technical advice and input to WHO activities on monitoring alcohol consumption and treatment capacity for substance use disorders in its Member States. </p> <p> </p> <p>Data compilation is to be performed centrally by WHO and UNODC based on data collected from countries that later will be validated through official focal points. </p> English 1204 characters edited Current translation Read only <p>At UNODC, quality assurance measures are in place to collect, process and disseminate statistical data. They build on the ‘Principles governing international statistical activities’ and regulate the collection, processing, publication and dissemination of data. </p> <p> </p> <p>All data for SDG indicators as compiled by the Office are sent to countries (through the relevant national focal points) for their review before statistical data are officially released by UNODC. When countries provide feedback/comments on the data, a technical discussion is conducted to identify a common position. </p> <p> </p> <p>At WHO quality assurance measures are in place for producing the health statistics that include the main indicators on alcohol consumption and its health consequences. WHO Technical Advisory Group on Alcohol and Drug Epidemiology provides technical advice and input to WHO activities on monitoring alcohol consumption and treatment capacity for substance use disorders in its Member States. </p> <p> </p> <p>Data compilation is to be performed centrally by WHO and UNODC based on data collected from countries that later will be validated through official focal points. </p> a year ago
None String updated in the repository SDG Metadata / 3-5-1 — English	English <p>UNODC has published a series of methodological guidelines on several issues related to the drug problem, entitled “Global Assessment Program (GAP)”. These guidelines consist of 8 modules, covering different aspects of monitoring the drug situation including setting up drug information systems, estimating drug prevalence using indirect methods, setting up treatment monitoring and reporting systems, etc. The modules can be found at: <a href="https://www.unodc.org/unodc/en/GAP/" target="_blank">https://www.unodc.org/unodc/en/GAP/</a>. It is planned to update these guidelines in the near future. </p> <p> </p> <p>As part of the ARQ review process, UNODC is planning to enhance its capacity building tools by complementing regional and national capacity building activities with: </p> <ul> <li>E-learning training modules with incorporated training curricula </li> <li>Creating methodological guidelines and tools on drug-related issues, including drug use disorders and treatment </li> <li>promoting national coordination mechanisms on drugs data, including national drug observatories </li> </ul> <p>WHO has published series of documents on alcohol monitoring in populations (e.g. International Guide for Monitoring Alcohol Consumption and Related Harm), and established a <a href="https://www.who.int/substance_abuse/activities/gisah/en/" target="_blank">Global Information System on Alcohol and Health (GISAH)</a> that provides easy and rapid access to a wide range of alcohol-related health indicators. It is an essential tool for assessing and monitoring the health situation and trends related to alcohol consumption, alcohol-related harm, and policy responses in countries. GISAH is a further development of the Global Alcohol Database which has been built since 1997 by the WHO Department of Mental Health and Substance Abuse. The main purpose of GISAH is to serve WHO Member States and governmental and nongovernmental organizations by making alcohol-related health data available. These data can help to analyse the state of the health situation related to alcohol in a country, a WHO region or sub-region, or the world. <a href="https://www.who.int/substance_abuse/activities/gisah_indicatorbook.pdf?ua=1" target="_blank">The Indicator Code Book</a> has been prepared to assist countries in collecting the data. </p> English 2353 characters edited Current translation Read only <p>UNODC has published a series of methodological guidelines on several issues related to the drug problem, entitled “Global Assessment Program (GAP)”. These guidelines consist of 8 modules, covering different aspects of monitoring the drug situation including setting up drug information systems, estimating drug prevalence using indirect methods, setting up treatment monitoring and reporting systems, etc. The modules can be found at: <a href="https://www.unodc.org/unodc/en/GAP/" target="_blank">https://www.unodc.org/unodc/en/GAP/</a>. It is planned to update these guidelines in the near future. </p> <p> </p> <p>As part of the ARQ review process, UNODC is planning to enhance its capacity building tools by complementing regional and national capacity building activities with: </p> <ul> <li>E-learning training modules with incorporated training curricula </li> <li>Creating methodological guidelines and tools on drug-related issues, including drug use disorders and treatment </li> <li>promoting national coordination mechanisms on drugs data, including national drug observatories </li> </ul> <p>WHO has published series of documents on alcohol monitoring in populations (e.g. International Guide for Monitoring Alcohol Consumption and Related Harm), and established a <a href="https://www.who.int/substance_abuse/activities/gisah/en/" target="_blank">Global Information System on Alcohol and Health (GISAH)</a> that provides easy and rapid access to a wide range of alcohol-related health indicators. It is an essential tool for assessing and monitoring the health situation and trends related to alcohol consumption, alcohol-related harm, and policy responses in countries. GISAH is a further development of the Global Alcohol Database which has been built since 1997 by the WHO Department of Mental Health and Substance Abuse. The main purpose of GISAH is to serve WHO Member States and governmental and nongovernmental organizations by making alcohol-related health data available. These data can help to analyse the state of the health situation related to alcohol in a country, a WHO region or sub-region, or the world. <a href="https://www.who.int/substance_abuse/activities/gisah_indicatorbook.pdf?ua=1" target="_blank">The Indicator Code Book</a> has been prepared to assist countries in collecting the data. </p> a year ago
None String updated in the repository SDG Metadata / 3-5-1 — English	English <p><strong>At country level </strong></p> <p>For drug use disorder, data will be provided for countries where information is available for both numerator and denominator. No data estimates will be done at the national level. </p> <p> </p> <p>For alcohol, when information on service utilization is missing in a country, several approaches will be used to produce estimates based on all available pieces of contextual service capacity data in the country and regionally. Link to be established between service availability and service utilization to get rough understanding on number of people who might be using services for countries where no direct information on number of people using services is available at all. </p> <p><strong> </strong></p> <p><strong>At regional and global level </strong></p> <p>Sub-regional and regional aggregates are produced when enough data at the country level are available (a minimum number of countries and a minimum percentage of population coverage). When data are available, sub-regional estimates are created first and then aggregated at regional level. The global level is computed as aggregation of regional estimates. </p> English 1166 characters edited Current translation Read only <p><strong>At country level </strong></p> <p>For drug use disorder, data will be provided for countries where information is available for both numerator and denominator. No data estimates will be done at the national level. </p> <p> </p> <p>For alcohol, when information on service utilization is missing in a country, several approaches will be used to produce estimates based on all available pieces of contextual service capacity data in the country and regionally. Link to be established between service availability and service utilization to get rough understanding on number of people who might be using services for countries where no direct information on number of people using services is available at all. </p> <p><strong> </strong></p> <p><strong>At regional and global level </strong></p> <p>Sub-regional and regional aggregates are produced when enough data at the country level are available (a minimum number of countries and a minimum percentage of population coverage). When data are available, sub-regional estimates are created first and then aggregated at regional level. The global level is computed as aggregation of regional estimates. </p> a year ago
None String updated in the repository SDG Metadata / 3-5-1 — English	English <p>The indicator will be computed by dividing the number of people receiving treatment services at least once in a year by the total number of people with substance use disorders in the same year: </p> <p><math xmlns="http://www.w3.org/1998/Math/MathML"> <msub> <mrow> <mi>C</mi> <mi>o</mi> <mi>v</mi> <mi>e</mi> <mi>r</mi> <mi>a</mi> <mi>g</mi> <mi>e</mi> </mrow> <mrow> <mi>S</mi> <mi>U</mi> <mi>D</mi> </mrow> </msub> <mo>=</mo> <mfrac> <mrow> <mi mathvariant="normal">&nbsp;</mi> <mi mathvariant="normal">n</mi> <mi mathvariant="normal">u</mi> <mi mathvariant="normal">m</mi> <mi mathvariant="normal">b</mi> <mi mathvariant="normal">e</mi> <mi mathvariant="normal">r</mi> <mi mathvariant="normal">&nbsp;</mi> <mi mathvariant="normal">o</mi> <mi mathvariant="normal">f</mi> <mi mathvariant="normal">&nbsp;</mi> <mi mathvariant="normal">p</mi> <mi mathvariant="normal">e</mi> <mi mathvariant="normal">o</mi> <mi mathvariant="normal">p</mi> <mi mathvariant="normal">l</mi> <mi mathvariant="normal">e</mi> <mi mathvariant="normal">&nbsp;</mi> <mi mathvariant="normal">i</mi> <mi mathvariant="normal">n</mi> <mi mathvariant="normal">&nbsp;</mi> <mi mathvariant="normal">t</mi> <mi mathvariant="normal">r</mi> <mi mathvariant="normal">e</mi> <mi mathvariant="normal">a</mi> <mi mathvariant="normal">t</mi> <mi mathvariant="normal">m</mi> <mi mathvariant="normal">e</mi> <mi mathvariant="normal">n</mi> <mi mathvariant="normal">t</mi> <mi mathvariant="normal">&nbsp;</mi> <mi mathvariant="normal">f</mi> <mi mathvariant="normal">o</mi> <mi mathvariant="normal">r</mi> <mi mathvariant="normal">&nbsp;</mi> <mi mathvariant="normal">S</mi> <mi mathvariant="normal">U</mi> <mi mathvariant="normal">D</mi> <mi mathvariant="normal">&nbsp;</mi> </mrow> <mrow> <mi mathvariant="normal">n</mi> <mi mathvariant="normal">u</mi> <mi mathvariant="normal">m</mi> <mi mathvariant="normal">b</mi> <mi mathvariant="normal">e</mi> <mi mathvariant="normal">r</mi> <mi mathvariant="normal">&nbsp;</mi> <mi mathvariant="normal">o</mi> <mi mathvariant="normal">f</mi> <mi mathvariant="normal">&nbsp;</mi> <mi mathvariant="normal">p</mi> <mi mathvariant="normal">e</mi> <mi mathvariant="normal">o</mi> <mi mathvariant="normal">p</mi> <mi mathvariant="normal">l</mi> <mi mathvariant="normal">e</mi> <mi mathvariant="normal">&nbsp;</mi> <mi mathvariant="normal">w</mi> <mi mathvariant="normal">i</mi> <mi mathvariant="normal">t</mi> <mi mathvariant="normal">h</mi> <mi mathvariant="normal">&nbsp;</mi> <mi mathvariant="normal">S</mi> <mi mathvariant="normal">U</mi> <mi mathvariant="normal">D</mi> </mrow> </mfrac> <mi>X</mi> <mi mathvariant="normal">&nbsp;</mi> <mn>100</mn> </math></p> <p> </p> <p>Where: SUD – Substance use disorders </p> English 3454 characters edited Current translation Read only <p>The indicator will be computed by dividing the number of people receiving treatment services at least once in a year by the total number of people with substance use disorders in the same year: </p> <p><math xmlns="http://www.w3.org/1998/Math/MathML"> <msub> <mrow> <mi>C</mi> <mi>o</mi> <mi>v</mi> <mi>e</mi> <mi>r</mi> <mi>a</mi> <mi>g</mi> <mi>e</mi> </mrow> <mrow> <mi>S</mi> <mi>U</mi> <mi>D</mi> </mrow> </msub> <mo>=</mo> <mfrac> <mrow> <mi mathvariant="normal">&nbsp;</mi> <mi mathvariant="normal">n</mi> <mi mathvariant="normal">u</mi> <mi mathvariant="normal">m</mi> <mi mathvariant="normal">b</mi> <mi mathvariant="normal">e</mi> <mi mathvariant="normal">r</mi> <mi mathvariant="normal">&nbsp;</mi> <mi mathvariant="normal">o</mi> <mi mathvariant="normal">f</mi> <mi mathvariant="normal">&nbsp;</mi> <mi mathvariant="normal">p</mi> <mi mathvariant="normal">e</mi> <mi mathvariant="normal">o</mi> <mi mathvariant="normal">p</mi> <mi mathvariant="normal">l</mi> <mi mathvariant="normal">e</mi> <mi mathvariant="normal">&nbsp;</mi> <mi mathvariant="normal">i</mi> <mi mathvariant="normal">n</mi> <mi mathvariant="normal">&nbsp;</mi> <mi mathvariant="normal">t</mi> <mi mathvariant="normal">r</mi> <mi mathvariant="normal">e</mi> <mi mathvariant="normal">a</mi> <mi mathvariant="normal">t</mi> <mi mathvariant="normal">m</mi> <mi mathvariant="normal">e</mi> <mi mathvariant="normal">n</mi> <mi mathvariant="normal">t</mi> <mi mathvariant="normal">&nbsp;</mi> <mi mathvariant="normal">f</mi> <mi mathvariant="normal">o</mi> <mi mathvariant="normal">r</mi> <mi mathvariant="normal">&nbsp;</mi> <mi mathvariant="normal">S</mi> <mi mathvariant="normal">U</mi> <mi mathvariant="normal">D</mi> <mi mathvariant="normal">&nbsp;</mi> </mrow> <mrow> <mi mathvariant="normal">n</mi> <mi mathvariant="normal">u</mi> <mi mathvariant="normal">m</mi> <mi mathvariant="normal">b</mi> <mi mathvariant="normal">e</mi> <mi mathvariant="normal">r</mi> <mi mathvariant="normal">&nbsp;</mi> <mi mathvariant="normal">o</mi> <mi mathvariant="normal">f</mi> <mi mathvariant="normal">&nbsp;</mi> <mi mathvariant="normal">p</mi> <mi mathvariant="normal">e</mi> <mi mathvariant="normal">o</mi> <mi mathvariant="normal">p</mi> <mi mathvariant="normal">l</mi> <mi mathvariant="normal">e</mi> <mi mathvariant="normal">&nbsp;</mi> <mi mathvariant="normal">w</mi> <mi mathvariant="normal">i</mi> <mi mathvariant="normal">t</mi> <mi mathvariant="normal">h</mi> <mi mathvariant="normal">&nbsp;</mi> <mi mathvariant="normal">S</mi> <mi mathvariant="normal">U</mi> <mi mathvariant="normal">D</mi> </mrow> </mfrac> <mi>X</mi> <mi mathvariant="normal">&nbsp;</mi> <mn>100</mn> </math></p> <p> </p> <p>Where: SUD – Substance use disorders </p> a year ago
None String updated in the repository SDG Metadata / 3-5-1 — English	English <p>The two main challenges in terms of computing the SDG 3.5.1 indicator are the limited availability of household surveys on substance use and the under-reporting of use among survey respondents. </p> <p>Data reported from household surveys are one of the sources of information on of the number of people with substance use disorders. There are issues of under-reporting for certain psychoactive substances, in countries where stigma is associated to substance use and when a considerable proportion of the drug or alcohol using population is institutionalized, homeless or unreachable by population-based surveys. Additionally, being a relatively rare event, household surveys on substance use disorders require a large sample and can be costly. In order to address these issues, additional approaches (e.g. scale up methods) are increasingly used in household surveys to address undercount issues. These can be used in conjunction with special studies and/or additional information, in order to obtain reasonable estimates via indirect methods, such as benchmark/multiplier or capture-recapture methods. </p> <p> </p> <p>An additional step in data validation and country capacity building for monitoring treatment coverage for substance use disorders will be implemented during the next couple of years for in-depth data generation in a sample of countries from different regions and representing different levels of health system development. A rapid assessment tool for in-depth data generation is in the process of development by WHO. </p> <p> </p> <p>The indicator stresses on type, availability and coverage of services but does not necessarily provide information on the actual quality of the interventions/services provided. To address this, at national level, the proposed treatment indicator will be accompanied with contextual information on availability coverage, i.e. treatment capacity for substance use disorders to provide additional information for interpretation of the contact coverage data. </p> English 2018 characters edited Current translation Read only <p>The two main challenges in terms of computing the SDG 3.5.1 indicator are the limited availability of household surveys on substance use and the under-reporting of use among survey respondents. </p> <p>Data reported from household surveys are one of the sources of information on of the number of people with substance use disorders. There are issues of under-reporting for certain psychoactive substances, in countries where stigma is associated to substance use and when a considerable proportion of the drug or alcohol using population is institutionalized, homeless or unreachable by population-based surveys. Additionally, being a relatively rare event, household surveys on substance use disorders require a large sample and can be costly. In order to address these issues, additional approaches (e.g. scale up methods) are increasingly used in household surveys to address undercount issues. These can be used in conjunction with special studies and/or additional information, in order to obtain reasonable estimates via indirect methods, such as benchmark/multiplier or capture-recapture methods. </p> <p> </p> <p>An additional step in data validation and country capacity building for monitoring treatment coverage for substance use disorders will be implemented during the next couple of years for in-depth data generation in a sample of countries from different regions and representing different levels of health system development. A rapid assessment tool for in-depth data generation is in the process of development by WHO. </p> <p> </p> <p>The indicator stresses on type, availability and coverage of services but does not necessarily provide information on the actual quality of the interventions/services provided. To address this, at national level, the proposed treatment indicator will be accompanied with contextual information on availability coverage, i.e. treatment capacity for substance use disorders to provide additional information for interpretation of the contact coverage data. </p> a year ago
None String updated in the repository SDG Metadata / 3-5-1 — English	English <p>According to UNODC and WHO data, around 271 million people aged 15 to 64 years worldwide used an illicit drug at least once in 2017, about 2.3 billion people are current drinkers of alcohol, some 35 million of people suffer from drug use disorders and 289 million from alcohol use disorders. </p> <p> </p> <p>Substance use disorders are serious health conditions that present a significant burden for affected individuals, their families and communities. Untreated substance use disorders trigger substantial costs to society including lost productivity, increased health care expenditure, and costs related to criminal justice, social welfare, and other social consequences. Strengthening treatment services entails providing access to a comprehensive set of evidence-based interventions (-laid down in the international standards and guidelines) that should be available to all population groups in need. The indicator will inform the extent to which a range of evidence-based interventions for treatment of substance use disorder are available and are accessed by the population in need at country, regional and global level. </p> <p> </p> <p>Even though effective treatment exists, only a small amount of people with substance use disorders receive it. For instance, it is estimated that globally one out of 7 people with drug use disorders have access to or provided drug treatment services (World Drug Report 2019). <a href="https://www.who.int/gho/substance_abuse/en/" target="_blank">WHO ATLAS-Substance Use</a> data showed that in 2014 only 11.9 % (out of 103 responding) countries reported high coverage (40% or more) for alcohol dependence. SDG indicator 3.5.1 is crucial for measurement the progress towards strengthening the treatment of substance abuse worldwide as formulated in the Target 3.5. </p> <p> </p> English 1826 characters edited Current translation Read only <p>According to UNODC and WHO data, around 271 million people aged 15 to 64 years worldwide used an illicit drug at least once in 2017, about 2.3 billion people are current drinkers of alcohol, some 35 million of people suffer from drug use disorders and 289 million from alcohol use disorders. </p> <p> </p> <p>Substance use disorders are serious health conditions that present a significant burden for affected individuals, their families and communities. Untreated substance use disorders trigger substantial costs to society including lost productivity, increased health care expenditure, and costs related to criminal justice, social welfare, and other social consequences. Strengthening treatment services entails providing access to a comprehensive set of evidence-based interventions (-laid down in the international standards and guidelines) that should be available to all population groups in need. The indicator will inform the extent to which a range of evidence-based interventions for treatment of substance use disorder are available and are accessed by the population in need at country, regional and global level. </p> <p> </p> <p>Even though effective treatment exists, only a small amount of people with substance use disorders receive it. For instance, it is estimated that globally one out of 7 people with drug use disorders have access to or provided drug treatment services (World Drug Report 2019). <a href="https://www.who.int/gho/substance_abuse/en/" target="_blank">WHO ATLAS-Substance Use</a> data showed that in 2014 only 11.9 % (out of 103 responding) countries reported high coverage (40% or more) for alcohol dependence. SDG indicator 3.5.1 is crucial for measurement the progress towards strengthening the treatment of substance abuse worldwide as formulated in the Target 3.5. </p> <p> </p> a year ago

Browse all translation changes


Jun	Jul	Aug	Sep	Oct	Nov	Dec	Jan	Feb	Mar	Apr	May

23	File in original format as translated in the repository	YAML file
23	All strings, converted files enriched with comments; suitable for offline translation	Android String Resource	CSV	JSON	gettext PO	iOS strings	TBX	TMX	XLIFF 1.1 with gettext extensions	XLIFF 1.1	XLSX

Review strings changed by other users	`changed:>=2023-05-02 AND NOT changed_by:anonymous`	Add
Translated strings	`state:>=translated`	Add
Strings with comments	`has:comment`	Add
Strings with any failing checks	`has:check`	Add
Strings with suggestions from others	`has:suggestion AND NOT suggestion_author:anonymous`	Add
Approved strings with suggestions	`state:approved AND has:suggestion`	Add
All untranslated strings added the past month	`added:>=2023-05-02 AND state:<=needs-editing`	Add

SDG Metadata

3-5-1

English

Source strings

Strings status

Other components

Overview

String statistics

Activity in last 12 months

Quick numbers

Trends of last 30 days

Quick downloads

Customize download

Search